A clinical trial for semaglutide, the active ingredient in Ozempic, found that it improved blood sugar control in people with ...

Both semaglutide and tirzepatide for type 2 diabetes and weight loss are GLP-1 agonists, meaning they mimic the hormone.

I hear a lot of talk around our small town when someone becomes noticeably thinner. “He sure has lost a lot of weight.” “Did ...

The next generation of diabetes and weight loss drugs could come in pill form, deliver even greater weight loss results, and ...

Weight loss drugs like Ozempic have gained a lot of popularity However these medications are not without side effects One ...

GLP-1 drugs bought online or at compound pharmacies could cause harm, according to Tennessee Attorney General Jonathan ...

Semaglutide was developed as a medication for type 2 diabetes, garnering FDA approval in 2017. However, clinical trials and post-marketing surveys “clearly demonstrated that the drug also has ...

GLP-1 drugs currently being tested in China target complications associated with obesity such as heart disease, fatty liver ...

A new study, led by Professor John Deanfield from University College London (UCL), reveals that the anti-obesity medication semaglutide could significantly reduce the risk of heart attacks and ...

Over 100 cases of acute pancreatitis have been reported to UK health regulators this year, many tied to the newest GLP-1 drug ...

A study published in eBioMedicine found that the GLP-1 drug semaglutide — sold under brand names such as Ozempic, Rybelsus, and Wegovy — effectively decreased alcohol consumption in rats.